World Demand for Infection Prevention Products to Reach $130 Billion in 2017
World demand for infection prevention products is forecast to increase 6.4 percent annually to $130 billion in 2017. The upgrading and enforcement of patient and staff safety standards in healthcare facilities, coupled with an expanding volume of hospital, surgical, and outpatient procedures, will promote overall gains. China, the United States, India, Russia, Japan, Germany, France, Italy, Brazil, and the United Kingdom will comprise the 10 largest national markets, combining to account for nearly two-thirds of global demand in 2017. These and other trends are presented in World Infection Prevention Products, a new study from The Freedonia Group, Inc., a Cleveland-based industry market research firm. Â
Demand for infection prevention products in the United States, Western Europe, Japan, and virtually all other developed countries will expand at a below average pace through 2017 and beyond as their medical delivery systems are well established, meet the healthcare needs of most residents, and have already adopted stringent patient and medical staff safety standards. By contrast, growth in China, India, Brazil, and many other emerging economies will exceed the world average as their health care sectors are expanded, modernized, and adapted to formal infection prevention protocols.Â
Protective apparel and textiles will remain the top selling group of infection prevention products worldwide. Expanded efforts by hospitals and outpatient facilities to reduce the threat of healthcare-associated infections (HAIs) in operating rooms will promote the increasing use of high value-added, barrier enhanced surgical drapes, gowns, face masks, and other apparel. Safety enhanced medical devices will also fare well in the global marketplace as healthcare facilities seek improved safety in blood collection, catheterization, drug delivery, and surgical procedures. This product group serves two critical areas of infection prevention: the reduction of HAIs and the prevention of accidental needlesticks.
Source: The Freedonia Group, Inc.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
